tradingkey.logo
tradingkey.logo

Medtronic PLC

MDT
96.540USD
-0.730-0.75%
終値 12/26, 16:00ET15分遅れの株価
123.76B時価総額
25.98直近12ヶ月PER

Medtronic PLC

96.540
-0.730-0.75%

詳細情報 Medtronic PLC 企業名

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Medtronic PLCの企業情報

企業コードMDT
会社名Medtronic PLC
上場日Nov 21, 1977
最高経営責任者「CEO」Martha (Geoffrey S)
従業員数95000
証券種類Ordinary Share
決算期末Nov 21
本社所在地Building Two Parkmore Business Park West
都市DUBLIN
証券取引所NASDAQ OMX NASDAQ Basic NYSE
Ireland
郵便番号H91 4K49
電話番号1135314381700
ウェブサイトhttps://www.medtronic.com/
企業コードMDT
上場日Nov 21, 1977
最高経営責任者「CEO」Martha (Geoffrey S)

Medtronic PLCの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+0.89%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+0.41%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+0.89%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-81.26%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
他の
2.41B
28.11%
地域別USD
会社名
収益
比率
Rest of World
4.32B
50.37%
United States
4.22B
49.24%
Ireland
33.00M
0.38%
事業別
地域別
事業別USD
会社名
収益
比率
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
他の
2.41B
28.11%

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
他の
74.57%
株主統計
株主統計
比率
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
他の
74.57%
種類
株主統計
比率
Investment Advisor
46.90%
Investment Advisor/Hedge Fund
29.42%
Research Firm
4.18%
Pension Fund
2.40%
Bank and Trust
2.17%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Insurance Company
0.38%
Individual Investor
0.28%
他の
11.49%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
126.32M
9.85%
+1.88M
+1.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
67.84M
5.29%
-1.09M
-1.58%
Jun 30, 2025
State Street Investment Management (US)
59.83M
4.66%
-210.22K
-0.35%
Jun 30, 2025
JP Morgan Asset Management
26.31M
2.05%
-1.69M
-6.03%
Jun 30, 2025
Capital Research Global Investors
36.36M
2.83%
-5.21M
-12.53%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.23M
2.2%
+310.68K
+1.11%
Jun 30, 2025
MFS Investment Management
19.36M
1.51%
-1.24M
-6.04%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
13.77M
1.07%
-170.61K
-1.22%
Jun 30, 2025
BlackRock Financial Management, Inc.
15.63M
1.22%
+1.48M
+10.48%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
詳細を見る
Absolute Select Value ETF
比率4.89%
iShares U.S. Medical Devices ETF
比率4.4%
iShares Health Innovation Active ETF
比率4.26%
Cullen Enhanced Equity Income ETF
比率4.24%
USCF Dividend Income Fund
比率3.59%
JPMorgan Healthcare Leaders ETF
比率3.22%
Madison Dividend Value ETF
比率3.08%
Tema Heart & Health ETF
比率2.98%
Global X Aging Population ETF
比率2.98%
WisdomTree US AI Enhanced Value Fund
比率2.86%

配当金

過去5年間の配当金総支払額は 17.37B 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Dec 04, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 16, 2026 going ex on Dec 26, 2025 with reinvestment option
Dec 26, 2025
Jan 16, 2026
Dec 26, 2025
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
詳細を見る

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Medtronic PLCの上位5名の株主は誰ですか?

Medtronic PLCの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は126.32M株を保有しており、これは全体の9.85%に相当します。
BlackRock Institutional Trust Company, N.A.は67.84M株を保有しており、これは全体の5.29%に相当します。
State Street Investment Management (US)は59.83M株を保有しており、これは全体の4.66%に相当します。
JP Morgan Asset Managementは26.31M株を保有しており、これは全体の2.05%に相当します。
Capital Research Global Investorsは36.36M株を保有しており、これは全体の2.83%に相当します。

Medtronic PLCの株主タイプ上位3種は何ですか?

Medtronic PLCの株主タイプ上位3種は、
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

Medtronic PLC(MDT)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Medtronic PLCの株式を保有している機関は3723社あり、保有株式の総市場価値は約1.13Bで、全体の88.20%を占めています。2025Q2と比較して、機関の持ち株は1.08%増加しています。

Medtronic PLCの最大の収益源は何ですか?

FY2026Q1において、Cardiac Rhythm & Heart Failure部門がMedtronic PLCにとって最大の収益を生み出しており、その金額は1.71Bで、全収益の19.96%を占めています。
KeyAI